Subramaniam Mohana Devi, Iyer Mahalaxmi, Nair Aswathy P, Venkatesan Dhivya, Mathavan Sinnakaruppan, Eruppakotte Nimmisha, Kizhakkillach Soumya, Chandran Manoj Kumar, Roy Ayan, Gopalakrishnan Abilash Valsala, Vellingiri Balachandar
SN ONGC Department of Genetics and Molecular Biology, Vision Research Foundation, Chennai 600006, Tamil Nadu, India.
Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore 641 043, Tamil Nadu, India.
Genes Dis. 2020 Dec 5;9(3):610-637. doi: 10.1016/j.gendis.2020.11.020. eCollection 2022 May.
Ocular cells like, retinal pigment epithelium (RPE) is a highly specialized pigmented monolayer of post-mitotic cells, which is located in the posterior segment of the eye between neuro sensory retina and vascular choroid. It functions as a selective barrier and nourishes retinal visual cells. As a result of high-level oxygen consumption of retinal cells, RPE cells are vulnerable to chronic oxidative stress and an increased level of reactive oxygen species (ROS) generated from mitochondria. These oxidative stress and ROS generation in retinal cells lead to RPE degeneration. Various sources including mtDNA damage could be an important factor of oxidative stress in RPE. Gene therapy and mitochondrial transfer studies are emerging fields in ocular disease research. For retinal degenerative diseases stem cell-based transplantation methods are developed from basic research to preclinical and clinical trials. Translational research contributions of gene and cell therapy would be a new strategy to prevent, treat and cure various ocular diseases. This review focuses on the effect of oxidative stress in ocular cell degeneration and recent translational researches on retinal degenerative diseases to cure blindness.
眼部细胞,如视网膜色素上皮(RPE),是一层高度特化的有丝分裂后色素细胞单层,位于眼睛后段,介于神经感觉视网膜和血管脉络膜之间。它起着选择性屏障的作用,并滋养视网膜视觉细胞。由于视网膜细胞的高耗氧量,RPE细胞易受慢性氧化应激以及线粒体产生的活性氧(ROS)水平升高的影响。视网膜细胞中的这些氧化应激和ROS产生会导致RPE退化。包括线粒体DNA损伤在内的各种来源可能是RPE氧化应激的一个重要因素。基因治疗和线粒体转移研究是眼部疾病研究中的新兴领域。对于视网膜退行性疾病,基于干细胞的移植方法已从基础研究发展到临床前和临床试验阶段。基因和细胞治疗的转化研究贡献将是预防、治疗和治愈各种眼部疾病的新策略。本综述重点关注氧化应激在眼部细胞退化中的作用以及近期关于视网膜退行性疾病以治愈失明的转化研究。